At a glance
- Originator Scios
- Class Antiasthmatics; Bronchodilators; Cyclobutanes; Piperazines; Small molecules
- Mechanism of Action Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 19 Aug 1997 No-Development-Reported for Asthma in USA (Unknown route)
- 27 Oct 1994 Preclinical development for Asthma in USA (Unknown route)